InvestorsHub Logo
Followers 11
Posts 378
Boards Moderated 0
Alias Born 01/09/2013

Re: None

Thursday, 03/20/2014 9:00:51 AM

Thursday, March 20, 2014 9:00:51 AM

Post# of 34635
More news this morning. Adding intellectual property.


TapImmune Inc. (OTCQB: TPIVD), a clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease has filed a new patent application for a novel technology platform designed to enhance the visibility of cancer or infected cells to a patient’s immune system, a critical aspect of an effective vaccine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News